Physician profile
Mikhail Strut
NPI 1699970491
$1,129.58
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $323 · 2021: $65.76 · 2022: $86.79 · 2023: $200 · 2024: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orexo US, INC. | $371.94 | 2019-2022 | |
| Abbott Laboratories | $300.82 | 2023-2024 | Octrode, Axium |
| Pacira Therapeutics, INC. | $144.73 | 2020 | |
| Pfizer INC. | $76.80 | 2019-2023 | |
| Collegium Pharmaceutical, INC. | $66.26 | 2020-2023 | Belbuca |
| Biohaven Pharmaceutical Holding Company Ltd. | $49.89 | 2022 | |
| Mdd US Operations, LLC | $46.52 | 2019 | |
| Scilex Pharmaceuticals INC. | $17.15 | 2022 | |
| Shionogi INC | $15.90 | 2019 | |
| Indivior INC. | $13.92 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.04 | 2019 | |
| Alfasigma USA, INC. | $12.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mikhail Strut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.